Obsessive-Compulsive Disorder News

Recent findings indicated a small proportion of the population will experience persistent mental illness across multiple decades of adulthood, despite the potentially large proportion who may experience mental illness at some point in adulthood.

D-cycloserine augmentation of cognitive behavioral therapy was not superior to placebo among youth with obsessive-compulsive disorder, according to recent findings.

A comprehensive analysis of all available treatments for obsessive-compulsive disorder suggested a combination of psychotherapeutic and psychopharmacological interventions may be most effective to treat the disorder.

Symptoms of psychiatric disorders were more common among individuals who met criteria for workaholism than those who did not, according to recent findings.

ATLANTA — Eric Hollander, MD, a professor of psychiatry at Albert Einstein College of Medicine and director of the Compulsive, Impulsive and Autism Spectrum Disorder Program at the Montefiore Medical Center, outlines new methods of neuromodulation in obsessive-compulsive disorder and autism spectrum disorders.

Addictive use of video games and social media was significantly associated with mental health disorder symptoms, according to recent findings.

Findings from a randomized clinical trial indicated efficacy and tolerability of N-acetylcysteine, an amino acid shown to restore extracellular glutamate concentration in the nucleus accumbens, for skin-picking disorder.

Obsessive-compulsive disorder symptoms often occur prior to dementia diagnosis and are frequently accompanied by anxiety, depression and psychosis, according to data presented at the American Academy of Neurology Annual Meeting.

PHILADELPHIA — An exposure therapy guide improved therapist behaviors among community mental health therapists treating youth with obsessive-compulsive disorder, suggesting the guide may help increase implementation of exposure and response-prevention therapy.

PHILADELPHIA — In this video, Aron Tendler, MD, a practicing psychiatrist in south Florida and chief medical officer of Brainsway, discusses the benefits of deep transcranial magnetic stimulation (TMS) for depression and obsessive-compulsive disorder.